logo-loader
FinanceInvestments and investor services
Heritage Cannabis

Heritage Cannabis to acquire stake in DNA-testing cannabis company Endocanna

The LA company has created a DNA test that uses a saliva sample to identify an individual's genetic variants related to cannabinoid receptors and metabolism

"Acquisition" highlighted
Individual's genetic data can be used to guide cannabis strain and dosage decisions

Heritage Cannabis Holdings Corp (CSE:CANN) signed a letter of intent Wednesday to acquire 30% of Endocanna Health Inc in a $3 million deal.

Los Angeles-based Endocanna has created the Endocannabinoid DNA test that uses a saliva sample to identify an individual's genetic variants related to cannabinoid receptors and metabolism.

That data can then be used to guide users' strain and dosage decisions.

WATCH: Heritage Cannabis finishes large fund raise, purchases facility in Ft Erie, Ontario

As part of the deal, the companies will form a joint venture to represent the EndoDNA technology in Canada. The deal is expected to close by June 28. 

"We are excited to be combining our plans for our own Extraction and Medical Sciences divisions with the technology and expertise that Endocanna brings." Chief Science Officer Chris Spooner said. "By utilizing the science-based EndoDNA process, we will be better able to assist patients with selecting and dosing by developing formulations that address the unique pharmacogenomics of individuals."

Heritage is a Canadian cannabis provider focused on becoming a vertically integrated company. It currently owns Voyage Cannabis Corp and CannaCure Corp, two Health Canada-approved cannabis producers.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Quick facts: Heritage Cannabis

Price: $0.42

Market: CSE
Market Cap: $183.44 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Heritage Cannabis named herein, including the promotion by the Company of Heritage Cannabis in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Heritage Cannabis signs deal with Cronos to fill and pack vaporizers

Heritage Cannabis (CSE: CANN) President and CEO Clint Sharples joined Steve Darling from our Proactive Toronto studio to discuss details about their new deal with Cronos Group. Sharples talking about what they will provide and when. Sharples also giving Proactive and update on their...

on 07/30/2019

2 min read